TDAC stock news
This page provides real-time market news, earnings updates, and company announcements related to Translational Development Acquisition Corp. (TDAC).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-20 14:02 EST
ALGO Increases by 0.37% as Biotech Experiments Progress and Markets Fluctuate
Bitget-RWA2025-11-04 05:14:05
CareDx Reports Positive Data for AlloHeme in AML and MDS Post HCT
Finviz2026-02-16 17:36:39
Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy
Finviz2026-02-17 13:06:08
Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board
Finviz2026-02-17 13:48:44
NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immunochemotherapy in Patients with 1L Metastatic Gastric Cancer
Finviz2026-02-17 21:09:43
CervoMed's neflamapimod elected for inclusion in UK EXPERTS-ALS platform designed to prioritize promising treatments for Amyotrophic Lateral Sclerosis
Finviz2026-02-18 11:03:09
5 Essential Analyst Inquiries from 10x Genomics’ Q4 Earnings Conference
101 finance2026-02-19 10:36:49
NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform
Finviz2026-02-19 12:03:42
Leading Scientists Demonstrate How Seer's Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026
Finviz2026-02-19 12:03:42
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-02-19 12:33:03
Cocrystal Pharma's First Oral Norovirus Protease Inhibitor CDI-988 to be Featured at the International Society for Antiviral Research Conference (ICAR) 2026
Finviz2026-02-19 13:03:13
Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer
Finviz2026-02-19 21:04:00
Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen
Finviz2026-02-19 21:36:38
NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immunochemotherapy in Patients with 1L Metastatic Gastric Cancer
Finviz2026-02-17 21:09:43
CervoMed's neflamapimod elected for inclusion in UK EXPERTS-ALS platform designed to prioritize promising treatments for Amyotrophic Lateral Sclerosis
Finviz2026-02-18 11:03:09
5 Essential Analyst Inquiries from 10x Genomics’ Q4 Earnings Conference
101 finance2026-02-19 10:36:49
NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform
Finviz2026-02-19 12:03:42
Leading Scientists Demonstrate How Seer's Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026
Finviz2026-02-19 12:03:42
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-02-19 12:33:03
Cocrystal Pharma's First Oral Norovirus Protease Inhibitor CDI-988 to be Featured at the International Society for Antiviral Research Conference (ICAR) 2026
Finviz2026-02-19 13:03:13
Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer
Finviz2026-02-19 21:04:00
Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen
Finviz2026-02-19 21:36:38
TDAC stock chart
TDAC stock detailsTDAC stock price change
On the last trading day, TDAC stock closed at 10.51 USD, with a price change of 0.00% for the day.
Trade stock futuresAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more